📰 Beta Pharma News

Beta Pharma News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Beta Pharma. Real-time updates on events, politics, business and more.

DelveInsight Business Research, LLP: DelveInsight Evaluates a Robust RNA Interference Pipeline as Key 85+ Pharma Companies Set Foot in the RNA Interference Space

November 1, 2022

RNA interference clinical trial pipeline constitutes 85+ key companies continuously working towards developing 100+ RNA interference therapies, analyzes DelveInsight LAS VEGAS, Nov. 1,

United States United Kingdom Midi Pyrées Shruti Thakur Fite Biopharma Beta Pharma

Source: finanznachrichten.de

DelveInsight Evaluates a Robust RNA Interference Pipeline as Key 85+ Pharma Companies Set Foot in the RNA Interference Space

November 1, 2022

/PRNewswire/ -- DelveInsights RNA Interference Competitive Landscape – 2022 report provides comprehensive global coverage of available, marketed, and...

United States United Kingdom Midi Pyrées Shruti Thakur Fite Biopharma Beta Pharma

Source: prnewswire.com

Global CD47 Inhibitor Drug Clinical Trial Report 2022-2028: Magrolimab Developed by GlaxoSmithKline is One of the Most Promising CD47 Targeting Antibodies in Clinical Development

August 24, 2022

/PRNewswire/ -- The "Global CD47 Inhibitor Drug Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.coms offering. The global CD47...

Immuneonco Biopharma Beta Pharma Eli Lilly Laura Wood E St Office Hours Call Inhibitors Drug Clinical Trials Insight By Company

Source: prnewswire.com

China's self-developed lung cancer drug available nationwide - Xinhua

December 17, 2020

Source: Xinhua| Editor: huaxia Video PlayerClose HANGZHOU, Dec. 17 (Xinhua) -- Ensartinib hydrochloride, a targeted drug for lung cancer developed by a Chinese firm, has been available in hospitals and pharmacies nationwide since Wednesday, according to its developer Beta Pharma. The Guangzhou-based Sun Yat-sen University Cancer Center prescribed the medication on Wednesday, first in China. Lung cancer is Chinas leading cause of mortality and morbidity in malignant tumor diseases, among which a...

Beta Pharma Xinhua Ensartinib Sun Yan Chinese Academy Of Engineering Sun Yat Sen University Cancer Center Anaplastic Lymphoma Kinase

Source: xinhuanet.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation